Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Sickle cell disease (SCD) is a life-threatening genetic disorder affecting nearly 100,000 individuals in the United States and is associated with many acute and chronic complications requiring immediate medical attention. Two disease-modifying therapies, hydroxyurea and long-term blood transfusions, are available but underused.

Related collections

Author and article information

Journal

PubMed ID:: 25203083

DOI:: 10.1001/jama.2014.10517

Data availability:

Comments

Comment on this article

scite_

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Read this article at

JAMA Network: Coronavirus

Journal

Comment on this article